Skip to content

Sean Wharton

Eli Lilly (United States)

2 papers in the Anchorcite directory, published between 2021 and 2022, cited 10,084 times in total.

ORCID profile

Research topics

Frequent co-authors

  • John P.H. Wilding · 1 paper
  • Rachel Louise Batterham · 1 paper
  • Salvatore Calanna · 1 paper
  • Melanie Jane Davies · 1 paper
  • Luc F. Van Gaal · 1 paper
  • Ildiko Lingvay · 1 paper
  • Barbara M. McGowan · 1 paper
  • Julio Rosenstock · 1 paper

Papers

  1. Once-Weekly Semaglutide in Adults with Overweight or ObesityNew England Journal of Medicine · 2021 · 5,804 citations

    BACKGROUND: Obesity is a global health challenge with few pharmacologic options. Whether adults with obesity can achieve weight loss with once-weekly semaglutide at a dose of 2.4 mg as an adjunct to lifestyle intervention has not been confirmed. METHODS: In…

  2. Tirzepatide Once Weekly for the Treatment of ObesityNew England Journal of Medicine · 2022 · 4,280 citations

    BACKGROUND: Obesity is a chronic disease that results in substantial global morbidity and mortality. The efficacy and safety of tirzepatide, a novel glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist, in people with obesity are not known. METHODS: In this…

Metadata from OpenAlex (CC0).